CDC37L1 Antikörper (AA 275-287)
Kurzübersicht für CDC37L1 Antikörper (AA 275-287) (ABIN1886302)
Target
Alle CDC37L1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 275-287
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Synthetic peptide contain a sequence corresponding to a region within amino acids 275 and 287 (Q7L3B6) of CDC37L1
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- CDC37L1 (Cell Division Cycle 37-Like 1 (CDC37L1))
-
Andere Bezeichnung
- CDC37L1
-
Hintergrund
-
CDC37L1 is a cytoplasmic phosphoprotein that exists in complex with HSP90 (HSPCA, MIM 140571) as well as several other proteins involved in HSP90-mediated protein folding (Scholz et al., 2001 [PubMed 11413142]).[supplied by OMIM]
Synonyms: HARC, CDC37B, FLJ20639, RP11-6J24.5 -
Molekulargewicht
- 39 kDa
-
Gen-ID
- 55664
-
NCBI Accession
- NM_017913, NP_060383
Target
-